Acorn Creek Capital LLC Purchases 154 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Acorn Creek Capital LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 33.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 616 shares of the healthcare conglomerate’s stock after buying an additional 154 shares during the period. Acorn Creek Capital LLC’s holdings in UnitedHealth Group were worth $360,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in UNH. Swedbank AB acquired a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in UnitedHealth Group by 107.8% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after purchasing an additional 1,196,758 shares in the last quarter. Lone Pine Capital LLC acquired a new position in UnitedHealth Group during the second quarter valued at approximately $480,903,000. Dimensional Fund Advisors LP raised its position in UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after purchasing an additional 880,183 shares in the last quarter. Finally, Baillie Gifford & Co. raised its position in UnitedHealth Group by 1,125.4% during the second quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock valued at $455,281,000 after purchasing an additional 821,050 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $554.45 on Wednesday. The firm’s 50-day moving average price is $584.11 and its 200-day moving average price is $532.57. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $608.63. The firm has a market capitalization of $510.31 billion, a P/E ratio of 33.89, a P/E/G ratio of 1.66 and a beta of 0.58. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. During the same quarter in the prior year, the business earned $6.14 earnings per share. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were issued a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Analyst Ratings Changes

UNH has been the subject of several research analyst reports. Wells Fargo & Company upped their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price target for the stock from $481.00 to $647.00 in a report on Wednesday, July 17th. Truist Financial boosted their price objective on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, October 1st. Finally, Argus boosted their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Two analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $617.37.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.33% of the stock is currently owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.